Kiora Pharmaceuticals Stock Price on October 10, 2024
| KPRX Stock | USD 3.64 0.12 3.41% |
Below is the normalized historical share price chart for Kiora Pharmaceuticals extending back to February 13, 2015. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Kiora Pharmaceuticals stands at 3.64, as last reported on the 11th of December 2024, with the highest price reaching 3.69 and the lowest price hitting 3.50 during the day.
If you're considering investing in Kiora Stock, it is important to understand the factors that can impact its price. At this stage we consider Kiora Stock to be risky. Kiora Pharmaceuticals has Sharpe Ratio of 0.0212, which conveys that the firm had a 0.0212% return per unit of risk over the last 3 months. We have found twenty-eight technical indicators for Kiora Pharmaceuticals, which you can use to evaluate the volatility of the firm. Please verify Kiora Pharmaceuticals' Mean Deviation of 2.87, downside deviation of 4.02, and Risk Adjusted Performance of 0.0362 to check out if the risk estimate we provide is consistent with the expected return of 0.0817%.
At this time, Kiora Pharmaceuticals' Total Stockholder Equity is fairly stable compared to the past year. Common Stock Shares Outstanding is likely to rise to about 564.9 K in 2024, whereas Liabilities And Stockholders Equity is likely to drop slightly above 11.7 M in 2024. . At this time, Kiora Pharmaceuticals' Price To Sales Ratio is fairly stable compared to the past year. Price Book Value Ratio is likely to rise to 0.43 in 2024, whereas Price Earnings Ratio is likely to drop (0.21) in 2024. Kiora Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 31st of July 2015 | 200 Day MA 4.5038 | 50 Day MA 3.529 | Beta (0.29) |
Kiora |
Sharpe Ratio = 0.0212
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | KPRX | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 3.85 actual daily | 34 66% of assets are more volatile |
Expected Return
| 0.08 actual daily | 1 99% of assets have higher returns |
Risk-Adjusted Return
| 0.02 actual daily | 1 99% of assets perform better |
Based on monthly moving average Kiora Pharmaceuticals is performing at about 1% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Kiora Pharmaceuticals by adding it to a well-diversified portfolio.
Price Book 0.3517 | Enterprise Value Ebitda (1.03) | Price Sales 0.6818 | Shares Float 1.4 M | Wall Street Target Price 30.33 |
Related Headline
Unicycive Therapeutics Headline on 10th of October 2024
Acquisition by Aggarwal Gaurav of 5500000 shares of Unicyciv... by Aggarwal Gaurav
Filed transaction by Unicycive Therapeutics Director. Grant, award or other acquisition pursuant to Rule 16b-3
Kiora Pharmaceuticals Valuation on October 10, 2024
It is possible to determine the worth of Kiora Pharmaceuticals on a given historical date. On October 10, 2024 Kiora was worth 3.35 at the beginning of the trading date compared to the closed value of 3.26. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Kiora Pharmaceuticals stock. Still, in general, we apply an absolute valuation method to find Kiora Pharmaceuticals' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Kiora Pharmaceuticals where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Kiora Pharmaceuticals' related companies.
| Open | High | Low | Close | Volume | |
| 3.43 | 3.43 | 3.36 | 3.36 | 1,333 | |
10/10/2024 | 3.35 | 3.44 | 3.26 | 3.26 | 6,898 |
| 3.30 | 3.44 | 3.27 | 3.44 | 5,040 |
| Backtest Kiora Pharmaceuticals | | | Kiora Pharmaceuticals History | | | Kiora Pharmaceuticals Valuation | Previous | Next |
Kiora Pharmaceuticals Trading Date Momentum on October 10, 2024
| On October 11 2024 Kiora Pharmaceuticals was traded for 3.44 at the closing time. The top price for the day was 3.44 and the lowest listed price was 3.27 . The trading volume for the day was 5 K. The trading history from October 11, 2024 was a factor to the next trading day price jump. The trading delta at closing time against the next closing price was 5.52% . The trading delta at closing time against the current closing price is 4.60% . |
Kiora Pharmaceuticals Fundamentals Correlations and Trends
By evaluating Kiora Pharmaceuticals' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Kiora Pharmaceuticals' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Kiora financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Kiora Pharmaceuticals Stock history
Kiora Pharmaceuticals investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Kiora is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Kiora Pharmaceuticals will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Kiora Pharmaceuticals stock prices may prove useful in developing a viable investing in Kiora Pharmaceuticals
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 538 K | 564.9 K | |
| Net Loss | -14.8 M | -15.5 M |
Kiora Pharmaceuticals Quarterly Net Working Capital |
|
Kiora Pharmaceuticals Stock Technical Analysis
Kiora Pharmaceuticals technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Kiora Pharmaceuticals Period Price Range
Low | December 11, 2024
| High |
0.00 | 0.00 |
Kiora Pharmaceuticals cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Kiora Pharmaceuticals December 11, 2024 Market Strength
Market strength indicators help investors to evaluate how Kiora Pharmaceuticals stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Kiora Pharmaceuticals shares will generate the highest return on investment. By undertsting and applying Kiora Pharmaceuticals stock market strength indicators, traders can identify Kiora Pharmaceuticals entry and exit signals to maximize returns
Kiora Pharmaceuticals Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Kiora Pharmaceuticals' price direction in advance. Along with the technical and fundamental analysis of Kiora Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Kiora to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.0362 | |||
| Jensen Alpha | 0.1104 | |||
| Total Risk Alpha | (0.46) | |||
| Sortino Ratio | 0.0056 | |||
| Treynor Ratio | 0.5881 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Additional Tools for Kiora Stock Analysis
When running Kiora Pharmaceuticals' price analysis, check to measure Kiora Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Kiora Pharmaceuticals is operating at the current time. Most of Kiora Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Kiora Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Kiora Pharmaceuticals' price. Additionally, you may evaluate how the addition of Kiora Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.